You have no items in your cart.
Yuflyma, Biosimilar to Humira, Approved in EU for Chronic Inflammatory Diseases
IBD News Today
The European Commission (EC) has granted marketing authorization to Celltrion Healthcare‘s Yuflyma (CT-P17), a biosimilar to Humira (adalimumab). The marketing authorization includes all indications for which AbbVie’s Humira is approved, ... Read more